Literature DB >> 1541539

High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain.

M Nagahama1, J Sakurai.   

Abstract

125I-epsilon-toxin showed high affinity to rat brain homogenates and synaptosomal membrane fractions, having single binding phases with dissociation constants (Kds) of 2.5 and 3.3 nM, respectively. Treatment of synaptosomal membrane fractions with pronase and neuraminidase lowered the binding of the labeled toxin, whereas treatment with trypsin and phospholipase C did not. Heating of the fractions resulted in a decrease in the binding of the toxin. These data suggest that interaction of epsilon-toxin with cell membranes in the brain is facilitated by a sialoglycoprotein. On the other hand, treatment of the membrane fractions with lipase resulted in complete loss of binding, suggesting that the interaction may require an appropriate lipid environment. These data suggest the presence of specific binding sites in brain tissue for epsilon-toxin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541539      PMCID: PMC257620          DOI: 10.1128/iai.60.3.1237-1240.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Enterotoxemi of sheep. I. Effects of Clostridium perfringens type D toxin on the brains of sheep and mice.

Authors:  L A GRINER
Journal:  Am J Vet Res       Date:  1961-05       Impact factor: 1.156

2.  Distribution of labeled Clostridium perfringens epsilon toxin in mice.

Authors:  M Nagahama; J Sakurai
Journal:  Toxicon       Date:  1991       Impact factor: 3.033

3.  Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin.

Authors:  J Sakurai; M Nagahama
Journal:  Microb Pathog       Date:  1986-10       Impact factor: 3.738

4.  Isolation of synaptosomal and synaptic plasma membrane fractions.

Authors:  C W Cotman
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

Review 5.  Molecular pharmacology of botulinum toxin and tetanus toxin.

Authors:  L L Simpson
Journal:  Annu Rev Pharmacol Toxicol       Date:  1986       Impact factor: 13.820

6.  Contraction induced by Clostridium perfringens epsilon toxin in the isolated rat ileum.

Authors:  J Sakurai; M Nagahama; T Takahashi
Journal:  FEMS Microbiol Lett       Date:  1989-04       Impact factor: 2.742

7.  The inactivation of Clostridium perfringens epsilon toxin by treatment with tetranitromethane and N-acetylimidazole.

Authors:  J Sakurai; M Nagahama
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

8.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

9.  Tryptophan content of Clostridium perfringens epsilon toxin.

Authors:  J Sakurai; M Nagahama
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

10.  Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rats.

Authors:  J Sakurai; M Nagahama; Y Fujii
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

View more
  25 in total

1.  Binding component of Clostridium perfringens iota-toxin induces endocytosis in Vero cells.

Authors:  Masahiro Nagahama; Koichi Nagayasu; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Clostridium perfringens epsilon-toxin increases permeability of single perfused microvessels of rat mesentery.

Authors:  R H Adamson; J C Ly; M Fernandez-Miyakawa; S Ochi; J Sakurai; F Uzal; F E Curry
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability.

Authors:  Jingjing Kang; Jie Gao; Wenwu Yao; Lin Kang; Shan Gao; Hao Yang; Bin Ji; Ping Li; Jing Liu; Jiahao Yao; Wenwen Xin; Baohua Zhao; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2017-03-17       Impact factor: 3.452

4.  Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system.

Authors:  O Miyamoto; J Minami; T Toyoshima; T Nakamura; T Masada; S Nagao; T Negi; T Itano; A Okabe
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1.

Authors:  Susan E Ivie; Mark S McClain
Journal:  Biochemistry       Date:  2012-09-12       Impact factor: 3.162

6.  Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

7.  Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.

Authors:  L Petit; M Gibert; D Gillet; C Laurent-Winter; P Boquet; M R Popoff
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

Review 8.  Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane; Jackie K Cheung; James Theoret; Jorge P Garcia; Robert J Moore; Julian I Rood
Journal:  Vet Microbiol       Date:  2015-02-25       Impact factor: 3.293

9.  Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release.

Authors:  Etienne Lonchamp; Jean-Luc Dupont; Laetitia Wioland; Raphaël Courjaret; Corinne Mbebi-Liegeois; Emmanuel Jover; Frédéric Doussau; Michel R Popoff; Jean-Louis Bossu; Jean de Barry; Bernard Poulain
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

10.  Oligomerization of Clostridium perfringens epsilon toxin is dependent upon caveolins 1 and 2.

Authors:  Christine M Fennessey; Jinsong Sheng; Donald H Rubin; Mark S McClain
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.